Things We Do for No Reason™: Routine use of triple anticoagulant therapy in patients with both nonvalvular atrial fibrillation and percutaneous coronary intervention

J Hosp Med. 2022 Nov;17(11):917-920. doi: 10.1002/jhm.12831. Epub 2022 May 8.

Authors

Collins Garst¹, Anmol Pitliya¹, Michael Iannetti¹, Marco Caccamo²

Affiliations

¹ Camden Clark Medical Center, Parkersburg, West Virginia, USA.
² Department of Cardiology, West Virginia University School of Medicine, Morgantown, West Virginia, USA.

PMID: 35527539
DOI: 10.1002/jhm.12831

No abstract available

MeSH terms

Anticoagulants / therapeutic use
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Drug Therapy, Combination
Fibrinolytic Agents / therapeutic use
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / therapeutic use

Substances

Anticoagulants
Platelet Aggregation Inhibitors
Fibrinolytic Agents